PKM and leukemia: Micheliolide (MCL) specifically targeted the PKM2 residue C424, promoted tetramer formation, inhibited lysine 433 (K433) acetylation and inhibited PKM2 nuclear translocation in HL-60 cells, consequently reducing the proliferation and carcinogenesis of leukemia cells (Li et al., 2018c).